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Abstract
Objective To determine the risk of lung cancer associated with
exposure at home to the radioactive disintegration products of
naturally occurring radon gas
Design Collaborative analysis of individual data from 13
case-control studies of residential radon and lung cancer.
Setting Nine European countries.
Subjects 7148 cases of lung cancer and 14 208 controls.
Main outcome measures Relative risks of lung cancer and
radon gas concentrations in homes inhabited during the
previous 5-34 years measured in becquerels (radon
disintegrations per second) per cubic metre (Bq/m3) of
household air.
Results The mean measured radon concentration in homes of
people in the control group was 97 Bq/m3, with 11% measuring
> 200 and 4% measuring > 400 Bq/m3. For cases of lung
cancer the mean concentration was 104 Bq/m3. The risk of lung
cancer increased by 8.4% (95% confidence interval 3.0% to
15.8%) per 100 Bq/m3 increase in measured radon (P = 0.0007).
This corresponds to an increase of 16% (5% to 31%) per 100
Bq/m3 increase in usual radon—that is, after correction for the
dilution caused by random uncertainties in measuring radon
concentrations. The dose-response relation seemed to be linear
with no threshold and remained significant (P = 0.04) in
analyses limited to individuals from homes with measured
radon < 200 Bq/m3. The proportionate excess risk did not
differ significantly with study, age, sex, or smoking. In the
absence of other causes of death, the absolute risks of lung
cancer by age 75 years at usual radon concentrations of 0, 100,
and 400 Bq/m3 would be about 0.4%, 0.5%, and 0.7%,
respectively, for lifelong non-smokers, and about 25 times
greater (10%, 12%, and 16%) for cigarette smokers.
Conclusions Collectively, though not separately, these studies
show appreciable hazards from residential radon, particularly
for smokers and recent ex-smokers, and indicate that it is
responsible for about 2% of all deaths from cancer in Europe.
Introduction
In many countries exposure in the home to short lived radioac-
tive disintegration products of the chemically inert gas
radon-222 is responsible for about half of all non-medical expo-
sure to ionising radiation.1 Radon-222 arises naturally from the
decay of uranium-238, which is present throughout the earth’s
crust. It has a half life of four days, allowing it to diffuse through
soil and into the air before decaying by emission of an  particle
into a series of short lived radioactive progeny. Two of these,
polonium-218 and polonium-214, also decay by emitting  par-
ticles. If inhaled, radon itself is mostly exhaled immediately. Its
short lived progeny, however, which are solid, tend to be depos-
ited on the bronchial epithelium, thus exposing cells to  irradia-
tion.
Air pollution by radon is ubiquitous. Concentrations are low
outdoors but can build up indoors, especially in homes, where
most exposure of the general population occurs. The highest
concentrations to which workers have been routinely exposed
occur underground, particularly in uranium mines. Studies of
exposed miners have consistently found associations between
radon and lung cancer.2 3 Extrapolation from these studies
suggests that in many countries residential radon, which
involves lower exposure in much larger numbers of people,
could cause a substantial minority of all lung cancers. This is of
practical relevance because radon concentrations in existing
buildings can usually be reduced at moderate cost—for example,
by increasing underfloor ventilation—while low concentrations
can usually be ensured at reasonable or low cost in new
buildings—for example, by installing a radon proof barrier at
ground level. These extrapolations, however, depend on
uncertain assumptions because the levels of exposure in miners
that produced evident risk were usually much higher, lasted
only a few years, and took place under different particulate air
and other conditions.1–3 Moreover, history on smoking is often
lacking, or limited, in the studies of miners and some
miners were also exposed to other lung carcinogens such as
arsenic.
Studies to estimate directly the risk of lung cancer associated
with residential radon exposure over several decades have been
conducted in many European countries. Individually these
studies have not been large enough to assess moderate risks
reliably. Greater statistical power can be achieved by combining
information from several studies, but this cannot be done satis-
factorily from published information. Urban areas tend to have
lower radon concentrations than rural ones as the underlying
rock is usually sedimentary and more people live upstairs in
apartments. Urban areas also usually have a higher prevalence
of smoking. Hence, radon concentrations in homes tend to be
negatively correlated with smoking,4–6 and a large dataset is
needed to correct for this reliably. We therefore brought
together and reanalysed individual data from all European
studies of residential radon and lung cancer that satisfied
certain criteria.
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Methods
Included studies
This collaboration included all 13 European studies that
registered over 150 people with lung cancer and 150 controls,
incorporated detailed smoking histories, and sought radon
measurements7 in homes that these individuals had lived in dur-
ing the past 15 years or more. Information on demographic and
lifestyle variables was compiled for each person by using a com-
mon format, and radon measurements were expressed in
becquerels (Bq) (radon disintegrations per second) per cubic
metre of household air.
On the basis of information from the studies on miners,2 3 we
assumed that the period of radon exposure most relevant to the
risk of lung cancer was the 30 years ending five years before the
diagnosis of (or death from) lung cancer or, for those in the con-
trol group, before a corresponding index date.We excluded indi-
viduals for whom no radon measurements for this 30 year
period were available or with unknown smoking status. The
available radon measurements covered a mean of 23 years. For
relevant homes where radon measurements could not be
obtained (for example, because the house had been demolished),
we estimated the concentration indirectly as the mean of all the
radon measurements in the residences of control group
members in the relevant study area. Finally, to obtain the “meas-
ured radon concentration” for each individual, we calculated a
time weighted average of the radon concentrations in all the
homes occupied over the past 5-34 years with weights
proportional to the length of time the individual had lived in
each.
Statistical methods
We assessed the association between radon and lung cancer in
two ways. Firstly, a model was fitted in which the risk of lung can-
cer was proportional to (1+x) where x is measured radon
concentration and  the proportionate increase in risk per unit
increase in measured radon. Secondly, we subdivided cases and
controls by categories of measured radon concentration and
plotted relative risks across different categories against estimated
mean exposure levels in those categories. In both types of analy-
sis, confounding was controlled through stratification.
Radon measurements made in the same home but in differ-
ent years show considerable random variability, indicating some
uncertainty in the measured radon concentration for each indi-
vidual. Further random uncertainty arises as radon concentra-
tions in some homes could not be measured and were estimated
indirectly. Both types of uncertainty lead to “regression dilution,”
whereby the relation of risk to measured radon concentration is
substantially weaker than the relation of risk to “usual” (that is,
true long term average) concentration.5 6 8 We calculated
dose-response relations both with and without correction for this
and estimated a time weighted average usual radon concentra-
tion for each individual (see www.ctsu.ox.ac.uk/radonmethods
for further details).
Results
Our analysis included 7148 people with lung cancer and 14 208
controls. For cases of lung cancer the mean measured radon
concentration was 104 Bq/m3 while for controls the weighted
average of the study specific means, with weights proportional to
numbers of cases of lung cancer, was 97 Bq/m3 (table 1). Among
controls, the percentage who were lifelong non-smokers
increased as radon concentration increased (percentages were
39%, 40%, 41%, 46%, and 48% for measured radon < 100, 100-
199, 200-399, 400-799, and ≥ 800 Bq/m3 after stratification for
study, age, sex, and region of residence; P = 0.001 for trend).
Risk of lung cancer versus measured radon concentration
After we stratified for study, age, sex, region of residence, and
smoking the risk of lung cancer increased by 8.4% (95%
confidence interval 3.0% to 15.8%; P = 0.0007) per 100 Bq/m3
increase in measured radon concentration. We stratified for
smoking by first subdividing the individuals into seven categories
(lifelong non-smokers, current smokers of < 15, 15-24, or ≥ 25
cigarettes a day, ex-smokers for < 10 years or ≥ 10 years, and
others) and then further subdividing each group of current
smokers by the age at which they started smoking ( < 15, 15-17,
18-20, or ≥ 21 years or unknown) and each group of ex-smokers
by amount previously smoked ( < 15, 15-24, or ≥ 25 a day or
unknown). If smoking had been omitted from the stratification,
the risk of lung cancer would have increased by only 2.3% per
100 Bq/m3 increase in measured radon, and if it had been
included with only seven categories, the estimated increase
would have been 5.2%. In all subsequent analyses we used the full
smoking stratification.
The proportionate increase in risk was not strongly
influenced by any one study. When we re-estimated the risk
omitting each study in turn, it changed at most by a fifth. Nor did
it vary substantially according to the period used to calculate
radon exposures. The above analyses relate to measured radon
concentrations 5-34 years earlier. Measured radon in periods
5-14, 15-24, and 25-34 years earlier were highly correlated, so the
relation of risk to radon in each of these three periods was simi-
lar to that for the entire period (7.5%, 7.6%, and 6.6%,
respectively). When we considered radon concentrations
throughout the period 5-34 years earlier but with contributions
from periods 5-14, 15-24, and 25-34 years earlier weighted in
proportions 1.0:0.75:0.50, as suggested by the miners’ studies,2
the risk was unaltered, at 8.4% per 100 Bq/m3 of measured
radon.
When we subdivided study participants according to seven
categories of measured radon (table 2), the results were consist-
ent with a linear dose-response relation (fig 1). There was no sig-
nificant curvature of the best fitting regression line, and no point
differed significantly from this line. The linear relation remained
significant even when we limited analysis to measured
concentrations < 200 Bq/m3 (P = 0.04). When we compared
Table 1 European case-control studies of residential radon and lung cancer
Study
Mean year of
diagnosis
Mean measured radon concentration
(Bq/m3)*
Lung cancers Controls
Austria9 1983 267 130
Czech Republic10 1981 528 493
Finland (nationwide)11 1989 104 103
Finland (south)12 1982 221 212
France13 1995 138 131
Germany (eastern)14 1994 78 74
Germany (western)14 1993 49 51
Italy15 1995 113 102
Spain16 1993 123 137
Sweden (nationwide)17 1982 99 94
Sweden (never smokers)18 1990 79 72
Sweden (Stockholm)19 1985 131 136
United Kingdom6 1991 57 54
All studies 1990 104 97†
*Estimate for each individual is time weighted average of measurements in different
residences 5-34 years earlier.
†Weighted average, with weights proportional to study specific numbers of lung cancer cases.
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individuals with measured radon 100-199 Bq/m3 (mean 136
Bq/m3) versus those with measured radon < 100 Bq/m3 (mean
52 Bq/m3) the relative risk was 1.20 (95% confidence interval
1.03 to 1.30; P = 0.01). Models with no effect up to a “threshold”
dose and then a linear effect did not fit significantly better than a
linear effect with no threshold; in such models the upper 95%
confidence limit for a possible threshold was 150 Bq/m3
measured radon.
Effect modification
There was no good evidence that the proportionate increase in
lung cancer risk per 100 Bq/m3 measured radon differed by
study (P = 0.94), age (P = 0.93), sex (P = 0.19), or smoking status
(P = 0.98) (fig 2). We rejected a model in which the combined
effects of radon and smoking were additive (P = 0.05). When we
considered lifelong non-smokers separately the increase in risk
per 100 Bq/m3 was 10.6% (0.3% to 28.0%), and there was no evi-
dence that it varied according to age, sex, or smoking status of
the individual’s spouse (P = 0.46, 0.19, and 0.18, respectively).
Microscopic confirmation of the diagnosis of lung cancer was
available for 6310 individuals. The variation between the
dose-response relations for the four histological types, as
classified by the original studies, did not reach significance
(P = 0.07, fig 2). The increase in risk per 100 Bq/m3 measured
radon, however, was 31.2% (12.8% to 60.6%) for small cell lung
cancer, while for all other histological types combined it was
2.6% ( < 0% to 10.2%) (P = 0.03 for difference), in accordance
with the steeper dose-response relation reported for small cell
cancer in early studies of miners exposed to radon.2
Allowance for random uncertainties in estimates of radon
exposure
Measurements of radon concentrations in individuals’ homes
during the period 5-34 years previously are subject to substantial
uncertainty. This uncertainty is not symmetrical. For example, if
the true average long term concentration that an individual was
exposed to was actually 300 Bq/m3, then the measured value for
that individual could, by chance, be 500 too high (that is, 800
Bq/m3), especially if it depended on measurements in only one
or two homes, but it could not be 500 too low. Detailed investiga-
tion of all available data concerning the variability in radon con-
centrations when the same house was measured in two different
years suggests that, for most individuals with measured levels
above 800 Bq/m3, the measured value was substantially higher
than the usual or true long term average value.7 Hence, although
in the group with measured radon concentrations above 800
Bq/m3 the mean of the measured concentrations was 1204
Bq/m3, the estimated mean of their usual radon concentrations
was only 678 Bq/m3 (table 2). If the mean usual radon
concentration in this highly exposed group is only about half the
mean measured value, then the slope of the line of risk versus
usual radon concentration becomes about twice as steep as that
of the line of risk versus measured radon concentration. When
we re-estimated the risk of lung cancer, correcting for random
uncertainties in measuring radon concentrations, it increased to
16% (5% to 31%) per 100 Bq/m3 usual radon. The
dose-response relation with usual radon was consistent with a
linear model (fig 1). Again there was no evidence that the risk per
100 Bq/m3 differed according to age, sex, or smoking.7
Combined effect of smoking and radon on absolute risk of
lung cancer
For current smokers of 15-24 cigarettes a day the risk of lung
cancer relative to that in lifelong non-smokers was 25.8 (21.3 to
31.2) for men in all 13 studies combined (after stratification by
study, age, and region). Therefore, similarity of the relative risk
between smokers and lifelong non-smokers would imply
Table 2 Relative risk of lung cancer by radon concentration (Bq/m3) in homes 5-34 years previously
Range of measured
values
Mean (Bq/m3)
No of lung cancer cases/controls Relative risk (95% floated CI)Measured values Estimated usual values
<25 17 21 566/1474 1.00 (0.87 to 1.15)
25-49 39 42 1999/3905 1.06 (0.98 to 1.15)
50-99 71 69 2618/5033 1.03 (0.96 to 1.10)
100-199 136 119 1296/2247 1.20 (1.08 to 1.32)
200-399 273 236 434/936 1.18 (0.99 to 1.42)
400-799 542 433 169/498 1.43 (1.06 to 1.92)
≥800 1204 678 66/115 2.02 (1.24 to 3.31)
Total 104/97* 90/86* 7148/14 208 —
*Cases/controls. Weighted average for controls, with weights proportional to study specific numbers of cases. Note that as random variation in measured values is approximately logarithmic (so
measurement twice as big as usual value is about as likely as measurement half as big as usual value), means of measured values slightly exceed means of estimated usual values.
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Fig 1 Relative risk of lung cancer according to measured residential radon
concentration and usual residential radon concentration, with best fitting straight
lines (risks are relative to that at 0 Bq/m3)
Papers
BMJ Online First bmj.com page 3 of 6
substantial differences in absolute risk per 100 Bq/m3. If the risk
of lung cancer increases by about 16% per 100 Bq/m3 usual
radon, regardless of smoking status, then at usual radon levels of
0, 100, 400, and 800 Bq/m3, respectively, cumulative absolute
risks of lung cancer by age 75 years would be 0.41%, 0.47%,
0.67%, and 0.93% in lifelong non-smokers and 10.1%, 11.6%,
16.0%, and 21.6% in cigarette smokers (fig 3).
Discussion
We were able to assess directly the risks from residential radon
because our study involved large numbers of individuals with
lung cancer and large numbers of unaffected individuals, all with
detailed smoking histories. People with higher residential radon
concentrations tended to smoke less, so that assessment of the
magnitude of the risk associated with radon required detailed
stratification for smoking history including amount smoked and
age for current smokers, and years since stopping smoking and
amount smoked for ex-smokers. Such detailed stratification has
not previously been possible. Correction for the bias introduced
by random uncertainties in the estimation of individual residen-
tial radon concentrations was also important.
After stratification for smoking there was strong evidence of
an association between residential radon and lung cancer. The
dose-response relation seemed linear with no evidence of a
threshold, and a significant relation remained even among those
whose measured radon concentrations were below 200 Bq/m3.
Study (P=0.94 for heterogeneity)
Austria
Czech Republic
Finland (nationwide)
Finland (south)
France
Germany (eastern)
Germany (western)
Italy
Spain
Sweden (nationwide)
Sweden (never smokers)
Sweden (Stockholm)
United Kingdom
Age (years) (P=0.93 for trend)
<55
55-64
≥65
Sex (P=0.19 for heterogeneity)
Male
Female
Smoking (P=0.98 for heterogeneity)
Current cigarette smoker
Ex-smoker
Lifelong non-smoker
Other
Histological type (P=0.07 for heterogeneity)
Squamous cell
Adeno
Small cell
Other type
Unknown
Overall, using measured radon
Overall, using usual radon
183/188
171/713
881/1435
160/328
571/1209
945/1516
1323/2146
384/405
156/235
960/2045
258/487
196/375
960/3126
1100/2582
2506/4818
3542/6808
5521/10 388
1627/3820
3575/3322
2465/4930
884/5418
224/538
2479/14 208
1698/14 208
1379/14 208
754/14 208
838/14 208
7148/14 208
7148/14 208
46
19
3
6
11
18
-2
10
-11
11
24
12
4
-7
14
7
11
3
7
8
11
8
-1
6
31
3
8
8
16
No of lung
cancers/
controls
Percentage
increase in risk
per 100 Bq/m3
Percentage
increase in risk
per 100 Bq/m3
(95% CI)
-10 0 10 20 30 40 50
Fig 2 Percentage increase in risk of lung cancer per 100 Bq/m3 increase in measured radon concentration by study, age, sex, smoking, and histological type. Squares
have areas inversely proportional to the square of the standard error of the percentage increase. For the Spanish study, the present non-significantly negative estimate
differs from a previously published positive estimate based on quartiles of radon distribution.16 The negative estimate, based on individual radon concentrations, is
dominated by three cases and 17 controls with measured radon ≥400 Bq/m3
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Correction for measurement error
After we corrected for random uncertainties in the assessment of
radon concentrations, the dose-response relation in this study
remained linear but nearly doubled in strength, to 16% (5% to
31%) per 100 Bq/m3. The magnitude of the correction is
approximate as data on the variability between repeated
measurements made in the same dwelling in different years are
limited, but substantial correction is certainly necessary. There
are also random errors in the assessment of smoking, and, if it
had been possible to adjust for them, we would expect this to
increase further the estimated effect of radon as there is negative
confounding between smoking and radon. Radon concentra-
tions within a home vary from room to room and so the actual
radon concentration relevant to an individual will also vary,
depending on the amount of time spent in different rooms. This
is an additional source of random uncertainty and, if it could be
taken into account, the estimated effect of radon could increase
still further.
Our study was based on measurements of radon gas made in
the recent past. Any systematic increase in radon concentrations
over recent decades due, say, to increased energy efficiency
would be a further source of dilution in our present risk
estimates. Techniques to estimate historical radon concentra-
tions through measurements of accumulated radioactive
damage to the surfaces of glass objects that have been in the
home for many years are being developed and may help to over-
come this, but the uncertainties and biases associated with these
techniques, especially in the presence of environmental tobacco
smoke, are not fully understood.
Comparison with other studies of radon
Before correction for random uncertainties, the increased risk of
lung cancer of 8% (3% to 16%) per 100 Bq/m3 in these European
studies was consistent with that of 11% (0% to 28%) found in a
recent combined analysis of North American studies.21 The
European collaboration, however, has greater power and more
extreme statistical significance because it involves twice as many
cases of lung cancer and higher radon concentrations (10% of
measured values were > 200 Bq/m3 versus 5% in the North
American studies). Our results are also consistent with the
pooled results of two Chinese studies22 and with a meta-analysis
of the published results of 17 studies, which, however, found
marked heterogeneity between the different publications.23 This
heterogeneity disappeared in our analysis, in which data on each
separate individual were collated centrally and analysed with
uniform methods.
An analysis of miners exposed to concentrations below 0.5
“working levels” (approximately equivalent to 4600 Bq/m3 radon
gas in the home) suggested risks were 19-30% per 100 Bq/m3,
without correction for the effect of uncertainties in the
assessment of radon exposures.24 These estimates are higher
than, but compatible with, the present estimate of 16% (5% to
31%).
Absolute hazard of radon for smokers and non-smokers
If the proportionate increases in risk per unit exposure are
approximately independent of smoking history then, as lung
cancer is much commoner in cigarette smokers than in lifelong
non-smokers, radon poses a much greater absolute hazard to
cigarette smokers, and to recent ex-smokers, than to lifelong
non-smokers.
We have shown that residential radon produces substantial
hazards, particularly among smokers, even at concentrations
below the action levels currently recommended in many
countries of a few hundred Bq/m3. The 2000 report from the
United Nations Scientific Committee on the Effects of Atomic
Radiation provided estimates of mean radon concentrations in
dwellings for 29 European countries, with a population weighted
average of 59 Bq/m3.1 If this is approximately correct, and if the
excess risk of lung cancer is about 16% per 100 Bq/m3 through-
out a wide range of exposure levels, then radon in homes
currently accounts for about 9% of the deaths from lung cancer
and hence 2% of all cancer deaths in Europe. In most countries
residential radon concentrations vary widely, with levels in most
homes well below the national average but levels in a minority of
homes several times higher than the national average. High
radon concentrations can be reduced in existing houses at mod-
erate cost, and low concentrations can usually be achieved at rea-
sonable or low cost when new buildings are constructed.
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Fig 3 Cumulative absolute risk of death from lung cancer by age 75 years
versus usual radon concentration at home for cigarette smokers and lifelong
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What is already known on this topic
Exposure to the natural radioactive gas radon and its
disintegration products can cause lung cancer
Exposure to radon gas in the home accounts for about half
of all non-medical exposure to ionising radiation
High radon concentrations can be reduced in existing
houses at moderate cost, and low concentrations can usually
be ensured in new buildings at reasonable or low cost
What this study adds
After detailed stratification for smoking, there was strong
evidence of an association between the radon concentration
at home and lung cancer
The dose-response relation seemed to be linear, with no
evidence of a threshold dose, and there was a significant
dose-response relation even below currently recommended
action levels
The absolute risk to smokers and recent ex-smokers was
much greater than to lifelong non-smokers
Radon in the home accounts for about 9% of deaths from
lung cancer and about 2% of all deaths from cancer in
Europe
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